Royalty Pharma PLC

Royalty Pharma PLC(RPRX)價格預測

$63.110

+0.801 (+1.27%)收盤時

價格預測

1-Day Price Prediction
-1.87%
1-Week Prediction
-0.78%
1-Month Prediction
2026 Prediction
2030 Prediction

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

RPRX 相似圖表分析預測

Alphio's RPRX stock price prediction model matches the current Royalty Pharma PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $62.69 (-1.87%). The 1-week path is $63.38 (-0.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Royalty Pharma PLC 股票嗎?

Royalty Pharma PLC appears to be a good buy right now due to its strong financial performance, with a year-to-date change of +56.59% and a 1-year change of +68.23%. The company has also raised its full-year guidance to $3.4 billion to $3.5 billion, indicating robust growth potential. However, the main risk is its high forward P/E ratio of 47.85, which suggests that the stock may be overvalued if growth expectations do not materialize.

RPRX 股價於 Wednesday 收在 $63.11,此前上漲 +1.27%

Royalty Pharma PLC (RPRX) last closed at $63.88, gaining +1.22%. These facts feed the 1-day and 1-week RPRX price prediction above.

預測驅動因素

Royalty Pharma PLC(RPRX)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

相似圖表形態

近期走勢與 RPRX 最接近的股票,依相似度排序。

RPRX 季節性分析

Historically the probability of a positive September return for RPRX is 63.64%. March offers the highest probability of a positive month at 100.00%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始